Midostaurin Associated With Standard Chemotherapy in Patients With Core-binding Factor Leukemia

NCT03686345 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

34

Enrollment

OTHER

Sponsor class

Stopped didn't reach the primary endpoint

Conditions

Core Binding Factor Acute Myeloid Leukemia (CBF-AML)

Interventions

DRUG: Midostaurin

Sponsor

Niguarda Hospital